Nisa Investment Advisors
AGIO icon

Nisa Investment Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Nisa Investment Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.4K Buy
1,358
+845
+165% +$25.6K ﹤0.01% 1854
2026
Q1 		$17.4K Buy
513
+218
+74% +$6.18K ﹤0.01% 2068
2025
Q4 		$8.03K Sell
295
-485
-62% -$17K ﹤0.01% 2316
2025
Q3 		$31.3K Hold
780
– – ﹤0.01% 1799
2025
Q2 		$25.9K Sell
780
-42
-5% -$1.27K ﹤0.01% 1815
2025
Q1 		$24.1K Sell
822
-14
-2% -$464 ﹤0.01% 1807
2024
Q4 		$27.5K Buy
836
+127
+18% +$5.97K ﹤0.01% 1842
2024
Q3 		$31.5K Sell
709
-140
-16% -$6.36K ﹤0.01% 1766
2024
Q2 		$36.6K Buy
849
+58
+7% +$2.09K ﹤0.01% 1753
2024
Q1 		$23.1K Buy
791
+41
+5% +$1.1K ﹤0.01% 1842
2023
Q4 		$16.7K Sell
750
-1
-0.1% -$22 ﹤0.01% 1927
2023
Q3 		$18.6K Hold
751
– – ﹤0.01% 2043
2023
Q2 		$21.3K Buy
751
+266
+55% +$6.62K ﹤0.01% 2076
2023
Q1 		$11K Sell
485
-1,300
-73% -$34.5K ﹤0.01% 2141
2022
Q4 		$50K Hold
1,785
– – ﹤0.01% 1764
2022
Q3 		$49K Buy
1,785
+45
+3% +$1.21K ﹤0.01% 1741
2022
Q2 		$39K Buy
1,740
+1,300
+295% +$29.4K ﹤0.01% 1812
2022
Q1 		$13K Sell
440
-1,270
-74% -$38.8K ﹤0.01% 2144
2021
Q4 		$53K Sell
1,710
-1,120
-40% -$45.1K ﹤0.01% 1717
2021
Q3 		$131K Hold
2,830
– – ﹤0.01% 1581
2021
Q2 		$156K Buy
2,830
+30
+1% +$1.68K ﹤0.01% 1498
2021
Q1 		$145K Buy
2,800
+2,200
+367% +$109K ﹤0.01% 1591
2020
Q4 		$26K Sell
600
-1,858
-76% -$73.5K ﹤0.01% 2087
2020
Q3 		$86K Buy
2,458
+1,858
+310% +$81.4K ﹤0.01% 1585
2020
Q2 		$32K Hold
600
– – ﹤0.01% 1669
2020
Q1 		$21K Buy
+600
New +$27.7K ﹤0.01% 1697
2019
Q1 		– Sell
-4,642
Closed -$214K – 2031
2018
Q4 		$214K Hold
4,642
– – ﹤0.01% 1223
2018
Q3 		$358K Buy
+4,642
New +$373K ﹤0.01% 1188
2016
Q2 		– Sell
-200
Closed -$8K – 1859
2016
Q1 		$8K Buy
+200
New +$8.55K ﹤0.01% 1801

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Nisa Investment Advisors's AGIO Position: Q2 2026 in Review

Nisa Investment Advisors increased its Agios Pharmaceuticals (AGIO) stake by 165% in Q2 2026, buying an estimated $25.6K and bringing the position to 1,358 shares worth $50.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1854.

Nisa Investment Advisors first reported a position in AGIO in Q1 2016 and has held it in 29 quarters since. The position peaked at $358K in Q3 2018. 238 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Nisa Investment Advisors held 1,358 shares of Agios Pharmaceuticals worth $50.4K as of Q2 2026.
  • Nisa Investment Advisors bought 845 Agios Pharmaceuticals shares in Q2 2026, an estimated $25.6K.
  • Agios Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1854 holding.
  • Nisa Investment Advisors first reported a position in Agios Pharmaceuticals in Q1 2016 and has held it in 29 quarters since.
  • Nisa Investment Advisors's Agios Pharmaceuticals position peaked at $358K in Q3 2018.
  • 238 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.